IMU Biosciences announced that it has received £11.5 million in a round of funding led by new investor Molten Ventures Plc on January 24, 2024. The transaction included participation from new investor Life Extension Ventures and other individuals. Oliver Nussbaumer and inga Deakin from Molten Ventures Plc will join board of directors.